PMC:7589163 / 66552-66856 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T251","span":{"begin":13,"end":50},"obj":"Disease"},{"id":"T252","span":{"begin":35,"end":50},"obj":"Disease"},{"id":"T253","span":{"begin":41,"end":50},"obj":"Disease"}],"attributes":[{"id":"A251","pred":"mondo_id","subj":"T251","obj":"http://purl.obolibrary.org/obo/MONDO_0001577"},{"id":"A252","pred":"mondo_id","subj":"T252","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A253","pred":"mondo_id","subj":"T253","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Treatment of respiratory syncytial virus infection with vitamin A: a randomized placebo-controlled trial in Santiago. Dowell SF 1996 [38] ChildrenRCT Vitamin A (50,000 to 200,000 UI, dosed according to age) More rapid resolution of tachypnea (p = 0.01).Shorter duration of hospitalization (p = 0.09)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T631","span":{"begin":35,"end":40},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T632","span":{"begin":64,"end":68},"obj":"http://purl.obolibrary.org/obo/CLO_0001627"},{"id":"T633","span":{"begin":161,"end":162},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Treatment of respiratory syncytial virus infection with vitamin A: a randomized placebo-controlled trial in Santiago. Dowell SF 1996 [38] ChildrenRCT Vitamin A (50,000 to 200,000 UI, dosed according to age) More rapid resolution of tachypnea (p = 0.01).Shorter duration of hospitalization (p = 0.09)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T65329","span":{"begin":56,"end":65},"obj":"Chemical"},{"id":"T10822","span":{"begin":56,"end":63},"obj":"Chemical"},{"id":"T269","span":{"begin":126,"end":128},"obj":"Chemical"},{"id":"T270","span":{"begin":153,"end":162},"obj":"Chemical"},{"id":"T52352","span":{"begin":153,"end":160},"obj":"Chemical"}],"attributes":[{"id":"A90471","pred":"chebi_id","subj":"T65329","obj":"http://purl.obolibrary.org/obo/CHEBI_12777"},{"id":"A24389","pred":"chebi_id","subj":"T10822","obj":"http://purl.obolibrary.org/obo/CHEBI_33229"},{"id":"A20754","pred":"chebi_id","subj":"T269","obj":"http://purl.obolibrary.org/obo/CHEBI_71029"},{"id":"A11069","pred":"chebi_id","subj":"T270","obj":"http://purl.obolibrary.org/obo/CHEBI_17336"},{"id":"A2547","pred":"chebi_id","subj":"T52352","obj":"http://purl.obolibrary.org/obo/CHEBI_33229"}],"text":"Treatment of respiratory syncytial virus infection with vitamin A: a randomized placebo-controlled trial in Santiago. Dowell SF 1996 [38] ChildrenRCT Vitamin A (50,000 to 200,000 UI, dosed according to age) More rapid resolution of tachypnea (p = 0.01).Shorter duration of hospitalization (p = 0.09)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T127","span":{"begin":236,"end":245},"obj":"Phenotype"}],"attributes":[{"id":"A127","pred":"hp_id","subj":"T127","obj":"http://purl.obolibrary.org/obo/HP_0002789"}],"text":"Treatment of respiratory syncytial virus infection with vitamin A: a randomized placebo-controlled trial in Santiago. Dowell SF 1996 [38] ChildrenRCT Vitamin A (50,000 to 200,000 UI, dosed according to age) More rapid resolution of tachypnea (p = 0.01).Shorter duration of hospitalization (p = 0.09)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T416","span":{"begin":0,"end":117},"obj":"Sentence"},{"id":"T417","span":{"begin":119,"end":304},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Treatment of respiratory syncytial virus infection with vitamin A: a randomized placebo-controlled trial in Santiago. Dowell SF 1996 [38] ChildrenRCT Vitamin A (50,000 to 200,000 UI, dosed according to age) More rapid resolution of tachypnea (p = 0.01).Shorter duration of hospitalization (p = 0.09)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2804","span":{"begin":56,"end":65},"obj":"Chemical"},{"id":"2805","span":{"begin":153,"end":162},"obj":"Chemical"},{"id":"2824","span":{"begin":13,"end":50},"obj":"Disease"},{"id":"2825","span":{"begin":236,"end":245},"obj":"Disease"}],"attributes":[{"id":"A2804","pred":"tao:has_database_id","subj":"2804","obj":"MESH:D014801"},{"id":"A2805","pred":"tao:has_database_id","subj":"2805","obj":"MESH:D014801"},{"id":"A2824","pred":"tao:has_database_id","subj":"2824","obj":"MESH:D018357"},{"id":"A2825","pred":"tao:has_database_id","subj":"2825","obj":"MESH:D059246"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Treatment of respiratory syncytial virus infection with vitamin A: a randomized placebo-controlled trial in Santiago. Dowell SF 1996 [38] ChildrenRCT Vitamin A (50,000 to 200,000 UI, dosed according to age) More rapid resolution of tachypnea (p = 0.01).Shorter duration of hospitalization (p = 0.09)."}